DORIBAX PACKAGE INSERT PDF

Based on reported adverse drug reactions, it is not anticipated that Doribax will affect the ability to .. PACKAGE LEAFLET: INFORMATION FOR THE USER. Based on reported adverse drug reactions, it is not anticipated that Doribax will affect the ability to drive and Package leaflet: Information for the user. Doribax . Doripenem is an antibacterial drug. Bacterial resistance mechanisms that affect doripenem include drug inactivation . Package Insert data.

Author: Mauzuru Momi
Country: Chile
Language: English (Spanish)
Genre: Spiritual
Published (Last): 27 February 2011
Pages: 16
PDF File Size: 5.92 Mb
ePub File Size: 10.27 Mb
ISBN: 370-9-80204-880-2
Downloads: 52486
Price: Free* [*Free Regsitration Required]
Uploader: Mooguk

Microbiology Doripenem belongs to the carbapenem class of antimicrobials.

Doripenem for Injection

Variations in color within this range do not affect the potency of the product. Patients with Renal Impairment Table 2: Storage of Constituted Solutions Doribas constitution with sterile water for injection or 0. A local search option of this data can be found here.

The following formula may be used to estimate CrCl. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use whenever solution and container permit.

Doripenem is stable to hydrolysis by most beta-lactamases, including penicillinases and cephalosporinases produced by Gram-positive and Gram-negative bacteria, with the exception of carbapenem hydrolyzing beta-lactamases. Anaerobic microorganisms Bacteroides caccae Bacteroides fragilis Bacteroides thetaiotaomicron Bacteroides uniformis Bacteroides pacjage Peptostreptococcus micros.

The recommended dosage and administration by infection is described in Table 1: Reference s National Institutes of Health, U. In the absence of such data, local epidemiology inxert susceptibility patterns may contribute to the empiric selection of therapy.

Patients with seizure disorders controlled with valproic acid or sodium valproate will therefore be at an increased risk for inseert seizures. Pharmacodynamics———————————— Similar to other beta-lactam antimicrobial agents, the time that unbound plasma concentration of doripenem exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in animal models of infection.

  AMMA KODUKU RANKU KATHALU IN TELUGU PDF

Excretion Doripenem is primarily eliminated unchanged by the kidneys. Facultative Gram-negative microorganisms Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes Klebsiella oxytoca Morganella morganii Serratia marcescens. The serum creatinine used in the formula should pckage a steady state of renal function. Doripenem exerts its bactericidal activity by inhibiting bacterial cell wall biosynthesis.

Facultative Gram-positive microorganisms Staphylococcus aureus methicillin-susceptible isolates only Streptococcus agalactiae Streptococcus pyogenes.

Doripenem is a carbapenem with in vitro antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria. Interaction with Other Antimicrobials In vitro synergy tests with doripenem show doripenem has little potential to antagonize or be antagonized by other antibiotics e.

Mean SD renal clearance is Doripenem inactivates multiple essential penicillin-binding proteins PBPs resulting in inhibition of cell wall synthesis with subsequent cell death. At least 90 percent of the following microorganisms exhibit an in vitro minimal inhibitory concentration MIC less than or equal to the susceptible breakpoint for doripenem of organisms of the same type shown in Table 6.

Disclaimer The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment.

DORIBAX® (doripenem) powder – GlobalRPH

Metabolism Metabolism of doripenem to a microbiologically inactive ring-opened metabolite doripenem-M1 occurs primarily via dehydropeptidase-I. Mechanism s of Resistance Bacterial resistance mechanisms that affect doripenem include drug inactivation by carbapenem-hydrolyzing enzymes, mutant or acquired PBPs, decreased outer membrane permeability and active efflux. Reference Package Insert data.

The magnitude of this value, coupled pacckage the significant decrease in the elimination of doripenem with concomitant probenecid administration, suggests that doripenem packag both glomerular filtration and active tubular secretion.

Facultative Gram-positive microorganisms Streptococcus constellatus Streptococcus intermedius. The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment.

The safety and efficacy of doripenem in treating clinical infections due to these microorganisms has not been established in adequate and well-controlled clinical trials. The mean plasma terminal elimination half-life of doripenem in healthy packate adults is approximately 1 hour and mean SD plasma clearance is Aseptic packaage must be followed in preparation of the infusion solution. When culture and susceptibility information are available, they should be considered in selecting and modifying antibacterial therapy.

  EL LECTOR POR HORAS J.SANCHIS SINISTERRA PDF

Facultative Gram-negative microorganisms Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Facultative Gram-positive microorganisms Streptococcus constellatus Streptococcus intermedius Anaerobic microorganisms Bacteroides caccae Bacteroides fragilis Bacteroides thetaiotaomicron Bacteroides uniformis Bacteroides vulgatus Peptostreptococcus micros At least 90 percent of the following microorganisms exhibit an in vitro minimal inhibitory concentration MIC less than or equal to the susceptible breakpoint for doripenem of organisms of the same type shown in Table 6.

Evaluate if diarrhea occurs. Doripenem has been shown to be active against most isolates of the following microorganisms, both in vitro and in clinical infections. Facultative Gram-positive microorganisms Staphylococcus aureus methicillin-susceptible isolates only Streptococcus agalactiae Streptococcus pyogenes Facultative Gram-negative microorganisms Citrobacter freundii Enterobacter cloacae Enterobacter aerogenes ;ackage oxytoca Morganella morganii Serratia marcescens Pharmacodynamics———————————— Similar to other beta-lactam antimicrobial agents, the time that unbound plasma concentration of doripenem exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in animal models of infection.

Please review the latest applicable package insert for additional information and possible updates. Mechanism of Action Doripenem is an antibacterial drug. Facultative Gram-negative microorganisms Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa. Although cross-resistance may occur, some isolates resistant to other carbapenems may be susceptible to doripenem.

The final infusion solution concentration is approximately pacckage. In pooled human liver microsomes, no in vitro metabolism of doripenem could be detected, indicating that doripenem is not a substrate for hepatic CYP enzymes.